Author

Xu Cheng

University of Michigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:organoid / primary culture· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Aaron M. UdageriD· 1 shared Aki MorikawaiD· 1 shared Chia Jen Liu· 1 shared Ellen WoldiD· 1 shared Habib A. SerhaniD· 1 shared Jason A. HethiD· 1 shared Liwei BaoiD· 1 shared Matthew B. SoellneriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron M. UdagerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhancing precision medicine for patients with breast cancer brain metastases through functional drug testing

Ellen Wold, Nathan M. Merrill, Habib A. Serhan, Aaron M. Udager, Chia Jen Liu, Ning Gu, Liwei Bao, Zhaoping Qin, Xu Cheng, Peter Ulintz, Jason A. Heth, Matthew B. Soellner, Sofia D. Merajver, Aki Morikawa

This study uses patient-derived organoids to test drug responses in breast cancer brain metastases, showing subtype-specific variations and the potential of PI3K inhibitors regardless of PIK3CA mutation status.

bioRxiv · Apr 22, 2026 · PreprintCancer Biology